Min-Ho Kim Lab:Lab Members: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
Min-Ho Kim (talk | contribs)
No edit summary
Min-Ho Kim (talk | contribs)
No edit summary
Line 45: Line 45:
<h3>Eric Dyne, Ph.D candidate in School of Biomedical Sciences</h3>
<h3>Eric Dyne, Ph.D candidate in School of Biomedical Sciences</h3>
<font size=3>
<font size=3>
Eric has studied neurodegeneration since the beginning of his Ph.D. program after finishing his Bachelor's degree in Biological Sciences at Kent State University. The focus of his research is to further our understanding of neuroinflammation and autophagy in Alzheimer's disease, especially emphasizing the potential role of GPNMB in microglial cells in response to beta-amyloid plaques.     
Eric has studied neurodegeneration since the beginning of his Ph.D. program after finishing his Bachelor's degree in Biological Sciences at Kent State University. The focus of his research is to develop a minimally invasive, non-pharmacological strategy to remove toxic Aβ plaques by using a magnetic hyperthermia strategy towards the treatment of AD/ADRD.     
</font>
</font>
|}
|}

Revision as of 18:12, 31 January 2021

Home        Lab Members        Publications        Research        Teaching        Contact        News       


Min-Ho Kim, Ph.D.,Principal Investigator

Associate professor, Dept. of Biological Sciences, Kent State University

Email: mkim15@kent.edu / Phone: 330-672-1445

Prof. Kim's department profile

  • Postdoc training, Biomedical Engineering,University of California at Davis, CA
  • Ph.D, Bioengineering, Pennsylvania State University, University Park, PA

Graduate students

Eric Dyne, Ph.D candidate in School of Biomedical Sciences

Eric has studied neurodegeneration since the beginning of his Ph.D. program after finishing his Bachelor's degree in Biological Sciences at Kent State University. The focus of his research is to develop a minimally invasive, non-pharmacological strategy to remove toxic Aβ plaques by using a magnetic hyperthermia strategy towards the treatment of AD/ADRD.

Alhussain Ojaym, MSc, Ph.D program in School of Biomedical Sciences

Alhussain joined Kim lab in January 2019. He is currently in the Ph.D program in the school of Biomedical Sciences at Kent State University. He has B.Sc. in Medical Laboratory and MSc. in Biomedical Sciences- specialization in Medical & Molecular Immunology.

Alumni

  • Bing Yu, Research Associate, May 2013-August 2020.
  • Jess Krieger, Ph.D, August 2017-December 2020, Co-founder of Artemys Foods, Currently CEO and co-founder of Ohayo Valley.
  • Ronghui Song, Ph.D, August 2018-May 2020, Currently at Johnson and Johnson.
  • Layla Almutairi, Ph.D, January 2015-May 2020,Currently Assistant Professor at Princess Noora bint Abdulrahman University, Riyadh, Saudi Arabia.
  • Tara Rogers, B.S. Honors college These, May 2019, Currently in the School of Pharmacy at University of Pittsburgh.
  • Talib Alboslemy, Ph.D, November 2013-May 2018.
  • Baeckkyoung Sung, Postdoc Fellow, March 2013-Feb 2015, currently Senior Researcher at KIST Europe.

Undergraduate students

  • Meghan Cawood, September 2020- present.
  • Mitchell Filka, September 2016-May 2017.
  • Cyrus Mirhaidari, Cyrus joined our laboratory in October 2016.
  • Atem Yesinovskiy, Artem joined our laboratory in September 2017.
  • Michal Sittek, Undergraduate Researcher, April 2014-May 2015.
  • Deborah Douglas, Undergraduate Researcher, August 2013-April 2014.
  • Steven Shaffer, Undergraduate Researcher, October 2013-May 2015.
  • Yanyi Zang, Undergraduate Researcher, October 2014-April 2015.

Kim Lab lunch-Novemver 2017